Delays in Initiation of Acyclovir Therapy in Herpes Simplex Encephalitis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Diagnosis of herpes simplex encephalitis (HSE) is based on clinical findings, MRI, and detection of herpes simplex virus (HSV) DNA in cerebrospinal fluid (CSF) using polymerase chain reaction amplification. Delays in starting treatment are associated with poorer clinical outcomes. We assessed the timing of initiation of acyclovir therapy in HSE. Methods: Inpatient databases from seven hospitals in Winnipeg, Manitoba were used to identify individuals diagnosed with encephalitis and HSE from 2004 to 2009. The time taken to initiate therapy with acyclovir and the reasons for delays were determined. Results: Seventy-seven patients were identified; 69 (90%) received acyclovir; in the others a non-HSV infection was strongly suspected. Thirteen patients were subsequently confirmed to have HSE. Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE. The most common reason for delay was a failure to consider HSE in the differential diagnosis, despite suggestive clinical features. Where therapy was delayed in HSE patients, the decision to begin acyclovir was prompted by transfer of the patient to a different service (55%), recommendations by consultants (18%), imaging results (18%), and CSF pleocytosis (9%). Conclusions: Delays in initiating acyclovir for HSE are common, and are most often due to a failure to consider HSE in a timely fashion on presentation. In order to improve patient outcomes, physicians should be more vigilant for HSE, and begin acyclovir therapy expeditiously on the basis of clinical suspicion rather than waiting for confirmatory tests.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., Hartman, B. J., Kaplan, S. L., Scheld, W. M., & Whitley, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589747 · Cited by 1,193 · cited 1×
“Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE.”
BackgroundWhitley, R. J., Soong, S.-J., Dolin, R., Galasso, G. J., Ch'ien, L. T., Alford, C. A., & the Collaborative Study Group (1977) · New England Journal of Medicine · doi:10.1056/nejm197708112970601 · Cited by 711
Raschilas, F., Wolff, M., Delatour, F., Chaffaut, C., De Broucker, T., Chevret, S., Lebon, P., Canton, P., Rozenberg, F., & French Herpes Simplex Encephalitis Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/341405 · Cited by 528 · cited 1×
“Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE.”
BackgroundAronin, S. I., Peduzzi, P., & Quagliarello, V. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_1-199812010-00004 · Cited by 486 · cited 1×
“Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE.”
BackgroundProulx, N., Frechette, D., Toye, B., Chan, J., & Kravcik, S. (2005) · QJM · doi:10.1093/qjmed/hci047 · Cited by 454 · cited 1×
“Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE.”
BackgroundHerpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome
McGrath, N., Anderson, N. E., Croxson, M. C., & Powell, K. F. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.3.321 · Cited by 410 · cited 1×
“Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE.”
BackgroundHerpes Simplex Encephalitis: Clinical Assessment
Whitley, R. J. (1982) · JAMA · doi:10.1001/jama.1982.03320280037026 · Cited by 356 · cited 1×
“Among patients diagnosed with viral encephalitides other than HSE, the most common pathogen identified was West Nile virus (n=15), followed by Epstein-Barr virus (3), varicella-zoster virus (2) and cytomegalovirus (1).”
BackgroundCinque, P., Cleator, G. M., Weber, T., Monteyne, P., Sindic, C. J., & van Loon, A. M. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.4.339 · Cited by 261 · cited 1×
“Among patients diagnosed with viral encephalitides other than HSE, the most common pathogen identified was West Nile virus (n=15), followed by Epstein-Barr virus (3), varicella-zoster virus (2) and cytomegalovirus (1).”
BackgroundAuburtin, M., Wolff, M., Charpentier, J., Varon, E., Le Tulzo, Y., Girault, C., Mohammedi, I., Renard, B., Mourvillier, B., Bruneel, F., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239434.26669.65 · Cited by 245 · cited 1×
“Acyclovir was initiated a median of 21 hours (3-407) after presentation in encephalitis cases, and a median of 11 hours (3-118) in HSE.”
BackgroundUpdate on herpes simplex encephalitis.
Tyler, K. L. (2004) · PubMed · Cited by 177
Cited by
Tyler, K. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708714 · Cited by 275
Sili, U., Kaya, A., & Mert, A. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.010 · Cited by 214
Herpes Simplex Encephalitis: an Update
Gnann, J. W., & Whitley, R. J. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0568-7 · Cited by 191
Predictors of outcome in HSV encephalitis
Singh, T. D., Fugate, J. E., Hocker, S. E., Wijdicks, E. F. M., Aksamit, A. J., & Rabinstein, A. A. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7960-8 · Cited by 156
“The most common reasons for the delay in the initiation of therapy are the failure to consider HSE while awaiting the results of CSF analysis, relatively normal CSF findings with CSF white cell count\10/mm(3), chronic alcohol abuse, severe underlying disease and a delay in obtaining brain imaging following hospital ad…”
BackgroundRadmard, S., Reid, S., Ciryam, P., Boubour, A., Ho, N., Zucker, J., Sayre, D., Greendyke, W. G., Miko, B. A., Pereira, M. R., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00281 · Cited by 127
Metadata
- Authors
- Hughes, P. S., & Jackson, A. C.
- Affiliations
- University of Manitoba (CA)
- Corresponding author
- Jackson, Alan C.
- ORCID
- Jackson, Alan C.
- Venue
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Publisher
- Cambridge University Press (CUP)
- Published
- 2012-09
- Volume
- 39
- Issue
- 5
- Pages
- 644-648
- ISSN
- 0317-1671 (ISSN-L)
- 2057-0155
- OpenAlex
- W2044602866
- Cited by
- 44
- References
- 17
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 7 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- herpes simplex encephalitis, acyclovir, treatment delay, antiviral therapy initiation, differential diagnosis, cerebrospinal fluid pleocytosis, clinical suspicion, herpes simplex virus, encephalitis
- MeSH terms
- Acyclovir, Adolescent, Adult, Aged, Aged, 80 and over, Antiviral Agents, Diagnosis, Differential, DNA, Viral, Female, Herpes Simplex, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Retrospective Studies, Time Factors, Encephalitis, Herpes Simplex, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delays in Initiation of Acyclovir Therapy in Herpes Simplex Encephalitis. https://app.cochat.ai/papers/10.1017/s0317167100015390
- The paper
- Hughes, P. S., & Jackson, A. C. (2012). Delays in Initiation of Acyclovir Therapy in Herpes Simplex Encephalitis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100015390
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.